Therefore, some researchers speculated that ACE2 was possibly related to the severity of patients with COVID-19, and even a hypothesis of using inhibitors that block both ACE and ACE2 zinc metalloproteases and their downstream pathways in these patients was proposed (17). This evidence concerns the gene ACE2 and COVID-19.